These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11480547)

  • 21. Synthesis of new N-substituted benzodiazepine derivatives with potential anxiolytic activity.
    Kossakowski J; Zawadowski T; Turło J
    Acta Pol Pharm; 1997; 54(6):483-5. PubMed ID: 9604696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
    Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ
    J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.
    Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
    J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of potential metabolites of ethyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl] benzoate.
    Sunthankar PS; Berlin KD; Nelson EC; Thorne RL; Geno PW; Archer JC; Rolf LL; Bartels KE
    J Pharm Sci; 1993 May; 82(5):543-5. PubMed ID: 8360834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
    Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-[2-[(substituted chroman-8-yl)oxy]ethyl]-4-(4-methoxyphenyl)butylamines: synthesis and wide range of antagonism at the human 5-HT1A receptor.
    Yasunaga T; Naito R; Kontani T; Tsukamoto S; Nomura T; Yamaguchi T; Mase T
    J Med Chem; 1997 Apr; 40(8):1252-7. PubMed ID: 9111299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
    Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of various analog derivatives of ORG13514 as 5-HT1A ligands.
    Comoy C; Benarab A; Leinot M; Monteil A; Guillaumet G
    Farmaco; 1999; 54(11-12):791-9. PubMed ID: 10668181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6- and 8-hydroxy-3,4-dihydro-3-(dipropylamino)-2H-1-benzopyrans. Dopamine agonists with autoreceptor selectivity.
    Wise LD; DeWald HA; Hawkins ES; Reynolds DM; Heffner TG; Meltzer LT; Pugsley TA
    J Med Chem; 1988 Mar; 31(3):688-91. PubMed ID: 3346882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
    Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis.
    Suchanek B; Struppeck H; Fahrig T
    Eur J Pharmacol; 1998 Aug; 355(1):95-101. PubMed ID: 9754943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
    Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
    J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
    Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical pharmacology of B-20991, a 5-HT1A receptor agonist with anxiolytic activity.
    Beneytez ME; López Rodríguez ML; Rosado ML; Morcillo MJ; Orensanz L; Fuentes JA; Manzanares J
    Eur J Pharmacol; 1998 Mar; 344(2-3):127-35. PubMed ID: 9600646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain.
    Fabre V; Boni C; Mocaër E; Lesourd M; Hamon M; Laporte AM
    Eur J Pharmacol; 1997 Oct; 337(2-3):297-308. PubMed ID: 9430429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents.
    Abou-Gharbia M; Moyer JA; Patel U; Webb M; Schiehser G; Andree T; Haskins JT
    J Med Chem; 1989 May; 32(5):1024-33. PubMed ID: 2565399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.